Author:
Roth David,Bloom Roy D.,Molnar Miklos Z.,Reese Peter P.,Sawinski Deirdre,Sise Meghan E.,Terrault Norah A.
Reference120 articles.
1. KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease;Kidney Int Suppl,2008
2. KDOQI US commentary on the KDIGO clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in CKD;Gordon;Am J Kidney Dis,2008
3. ION-1 Investigators. Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection;Afdhal;N Engl J Med,2014
4. Glecaprevir-pibrentasvir for 8 or 12 weeks in HCV genotype 1 or 3 infection;Zeuzem;N Engl J Med,2018
5. Grazoprevir plus elbasvir in treatment-naive and treatment experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study;Roth;Lancet,2015
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献